McDaniel and 42 other attorneys
general asked the FDA to place a “black box” warning on opioid analgesics to
inform pregnant women about the risks of Neonatal Abstinence Syndrome (NAS) in
newborn children. NAS is caused when infants who have been exposed to
painkillers through their mother’s prenatal use suddenly lose their opioid drug
supply at birth. The withdrawal of opioids can cause symptoms in newborns that
include tremors, vomiting, high-pitch crying, hyperactivity, weight loss and
failure to gain weight.
“As the prescription drug abuse
problem grows here and Arkansas and across the country, hospitals are seeing
increasing numbers of infants who are born with serious health problems as a
result of their mothers' painkiller abuse,” McDaniel said. “There are very
serious risks associated with using narcotics during pregnancy, and we must do
everything we can to make sure expectant mothers and health-care providers are
fully aware of those risks.”
In 2009, approximately one infant
was born each hour in the United States with NAS, meaning those children have
significantly greater chances of having respiratory issues, low birth weight,
feeding difficulties and seizures. That same year, nationwide health-care costs
associated with treating NAS were estimated at $720 million. Medicaid paid for
the majority of those treatment costs.
While NAS is treatable, the best
course of action is to prevent the disease from occurring in the first place,
the attorneys general wrote in their letter to the FDA.
.
With the letter, McDaniel and
other state attorneys general continued their efforts to combat prescription
drug abuse, which is the fastest growing drug problem in the United States. The
Centers for Disease Control and Prevention has classified prescription drug
abuse as an epidemic. Prescription drug abuse is the leading cause of accidental
death in the United States and it now accounts for more deaths nationally than
traffic accidents.
In April, the FDA heeded the
bipartisan advice of McDaniel and other AGs by blocking generic drug
manufacturers from producing a crushable generic form of OxyContin, a drug that
has fueled addiction and overdoses across the country.
No comments:
Post a Comment